Dirk Haller

23.8k total citations · 9 hit papers
231 papers, 14.9k citations indexed

About

Dirk Haller is a scholar working on Molecular Biology, Genetics and Food Science. According to data from OpenAlex, Dirk Haller has authored 231 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Molecular Biology, 73 papers in Genetics and 52 papers in Food Science. Recurrent topics in Dirk Haller's work include Gut microbiota and health (123 papers), Inflammatory Bowel Disease (52 papers) and Probiotics and Fermented Foods (47 papers). Dirk Haller is often cited by papers focused on Gut microbiota and health (123 papers), Inflammatory Bowel Disease (52 papers) and Probiotics and Fermented Foods (47 papers). Dirk Haller collaborates with scholars based in Germany, United States and Switzerland. Dirk Haller's co-authors include Thomas Clavel, Eva Rath, Gabriele Hörmannsperger, Pedro A. Ruiz, Hannelore Daniel, Ilias Lagkouvardos, R. Balfour Sartor, Bernhard Watzl, Michaël Blaut and Sandra Reitmeier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Dirk Haller

222 papers receiving 14.6k citations

Hit Papers

Critical review: vegetables and fruit in the prevention o... 2010 2026 2015 2020 2012 2014 2013 2010 2016 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Critical review: vegetables and fruit in the prevention of chronic diseases
    2012 1.3k citations Dirk Haller et al. profile →
  2. A guide to histomorphological evaluation of intestinal inflammation in mouse models.
    2014 574 citations Dirk Haller et al. PubMed profile →
  3. High-fat diet alters gut microbiota physiology in mice
    2013 542 citations Hannelore Daniel, Amin Moghaddas Gholami et al. The ISME Journal profile →
  4. Safety assessment of probiotics for human use
    2010 526 citations Dirk Haller et al. Gut Microbes profile →
  5. IMNGS: A comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies
    2016 331 citations Ilias Lagkouvardos, Dirk Haller et al. profile →
  6. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence
    2015 315 citations Monika Schaubeck, Thomas Clavel et al. Gut profile →
  7. Network analysis methods for studying microbial communities: A mini review
    2021 197 citations Monica Steffi Matchado, Michael Lauber et al. profile →
  8. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
    2022 156 citations Amira Metwaly, Sandra Reitmeier et al. profile →
  9. Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature
    2023 79 citations Sebastian Jarosch, Andreas Wanisch et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Haller Germany 65 7.9k 2.7k 2.3k 2.1k 2.0k 231 14.9k
Benoît Chassaing United States 55 7.7k 1.0× 1.8k 0.7× 2.5k 1.1× 2.4k 1.1× 1.5k 0.7× 186 13.6k
Georgina L. Hold United Kingdom 54 9.6k 1.2× 2.3k 0.8× 2.0k 0.8× 1.8k 0.8× 1.5k 0.7× 142 15.1k
H. Rex Gaskins United States 63 7.6k 1.0× 2.6k 1.0× 2.1k 0.9× 1.5k 0.7× 1.9k 1.0× 172 14.9k
Karen Madsen Canada 58 6.6k 0.8× 2.3k 0.9× 1.9k 0.8× 2.4k 1.1× 1.6k 0.8× 187 12.5k
Elisabeth M. Bik United States 27 8.7k 1.1× 2.4k 0.9× 2.0k 0.9× 1.2k 0.6× 1.5k 0.8× 45 13.6k
Andrew L. Goodman United States 50 11.2k 1.4× 2.1k 0.8× 2.3k 1.0× 2.5k 1.2× 1.1k 0.5× 97 16.4k
Brandi L. Cantarel United States 29 11.4k 1.4× 1.9k 0.7× 3.0k 1.3× 1.5k 0.7× 1.6k 0.8× 42 16.5k
Daniel A. Peterson United States 36 8.7k 1.1× 2.3k 0.8× 2.1k 0.9× 1.5k 0.7× 1.3k 0.6× 60 13.0k
Johan Garssen Netherlands 74 7.7k 1.0× 2.3k 0.8× 3.9k 1.7× 1.6k 0.8× 4.0k 2.0× 657 21.6k
Philippe Langella France 61 10.7k 1.4× 5.0k 1.9× 2.6k 1.1× 2.5k 1.2× 2.3k 1.2× 232 16.0k

Countries citing papers authored by Dirk Haller

Since Specialization
Citations

This map shows the geographic impact of Dirk Haller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Haller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Haller more than expected).

Fields of papers citing papers by Dirk Haller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Haller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Haller. The network helps show where Dirk Haller may publish in the future.

Co-authorship network of co-authors of Dirk Haller

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Haller. A scholar is included among the top collaborators of Dirk Haller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Haller. Dirk Haller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khaloian, Sevana, Sebastian Jarosch, Amira Metwaly, et al.. (2025). Susceptibility to inflammatory bowel diseases promotes invasive carcinomas in a murine model of ATF6-driven colon cancer. Journal of Crohn s and Colitis. 19(7).
2.
Xian, Feng, Christoph Krisp, R. Ranjith Kumar, et al.. (2025). Ultra-sensitive metaproteomics redefines the dark metaproteome, uncovering host-microbiome interactions and drug targets in intestinal diseases. Nature Communications. 16(1). 6644–6644. 2 indexed citations
3.
Yoon, Hongsup, Lisa Ann Gerdes, Florian Beigel, et al.. (2025). Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice—An unbiased functional study. Proceedings of the National Academy of Sciences. 122(18). e2419689122–e2419689122. 2 indexed citations
4.
Wortmann, Esther, Marijana Basic, André Bleich, et al.. (2024). Gut microbiota prevents small intestinal tumor formation due to bile acids in gnotobiotic mice. PubMed. 3(4). 44–44.
5.
Jarosch, Sebastian, Andreas Wanisch, Klaus‐Peter Janssen, et al.. (2023). Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Gut. 72(7). 1258–1270. 79 indexed citations breakdown →
6.
Metwaly, Amira & Dirk Haller. (2023). The TNF∆ARE Model of Crohn’s Disease-like Ileitis. Inflammatory Bowel Diseases. 30(1). 132–145. 3 indexed citations
7.
Dietl, Andreas, Klaus‐Peter Janssen, Moritz Middelhoff, et al.. (2023). Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature. Zeitschrift für Gastroenterologie. 61(8). e404–e405. 6 indexed citations
8.
Matchado, Monica Steffi, Maximilian Zwiebel, Michael Lauber, et al.. (2022). Namco: a microbiome explorer. Microbial Genomics. 8(8). 10 indexed citations
9.
Schult, David, Sandra Reitmeier, Tobias Lahmer, et al.. (2022). Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19. Gut Microbes. 14(1). 2031840–2031840. 59 indexed citations
10.
Maurer, H. Carlo, David Schult, Sandra Reitmeier, et al.. (2022). Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis. Journal of Fungi. 8(12). 1265–1265.
11.
Kumar, Rahul, Ajay Kumar Chaudhary, Joseph R. Inigo, et al.. (2022). A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. Journal of Clinical Investigation. 132(13). 45 indexed citations
12.
Metwaly, Amira, Sandra Reitmeier, Theresa Baumeister, et al.. (2022). Analysis of Fecal, Salivary, and Tissue Microbiome in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma. SHILAP Revista de lepidopterología. 1(5). 755–766. 1 indexed citations
13.
Reitmeier, Sandra, Thomas C. A. Hitch, Nicole Treichel, et al.. (2021). Handling of spurious sequences affects the outcome of high-throughput 16S rRNA gene amplicon profiling. ISME Communications. 1(1). 31–31. 96 indexed citations
14.
Moitinho‐Silva, Lucas, Hila Emmert, Hansjörg Baurecht, et al.. (2021). Host traits, lifestyle and environment are associated with human skin bacteria. British Journal of Dermatology. 185(3). 573–584. 15 indexed citations
15.
Khaloian, Sevana, Eva Rath, Nassim Hammoudi, et al.. (2020). Mitochondrial impairment drives intestinal stem cell transition into dysfunctional Paneth cells predicting Crohn’s disease recurrence. Gut. 69(11). 1939–1951. 136 indexed citations
16.
Schaubeck, Monika, Thomas Clavel, Ilias Lagkouvardos, et al.. (2015). OP001. Transmissive Crohn's disease-like ileitis is caused by functional dysbiosis in the intestinal microbiota independent of inflammation-driven Paneth cell failure. Journal of Crohn s and Colitis. 9(suppl 1). S1–S1. 1 indexed citations
17.
Schaubeck, Monika, Thomas Clavel, Jelena Ćalasan, et al.. (2015). Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut. 65(2). 225–237. 315 indexed citations breakdown →
18.
Daniel, Hannelore, Amin Moghaddas Gholami, David Berry, et al.. (2013). High-fat diet alters gut microbiota physiology in mice. The ISME Journal. 8(2). 295–308. 542 indexed citations breakdown →
19.
Renz, Harald, Ingo B. Autenrieth, Per Brandtzæg, et al.. (2011). Gene-environment interaction in chronic disease: A European Science Foundation Forward Look. Journal of Allergy and Clinical Immunology. 128(6). S27–S49. 27 indexed citations
20.
Haller, Dirk, Jean‐Michel Antoine, Stig Bengmark, et al.. (2010). Guidance for substantiating the evidence for beneficial effects of probiotics: Probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome (Journal of Nutrition (2010) 140, (690S-697S)). Journal of Nutrition. 140(6). 1189. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benoît Chassaing Breakdown of academic impact, for papers by Georgina L. Hold Breakdown of academic impact, for papers by H. Rex Gaskins Breakdown of academic impact, for papers by Karen Madsen Breakdown of academic impact, for papers by Elisabeth M. Bik Breakdown of academic impact, for papers by Andrew L. Goodman Breakdown of academic impact, for papers by Brandi L. Cantarel Breakdown of academic impact, for papers by Daniel A. Peterson Breakdown of academic impact, for papers by Johan Garssen Breakdown of academic impact, for papers by Philippe Langella
Rankless by CCL
2026